1Yanni JM, Weimer LK, Sharif NA, et al.Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs [J] .Arch Ophthalmol, 1999 ,117 (5) :643-647.
2Leonardi A, DeFranchis G, De Paoli M, et al. Histamine-induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts [J] . Curr Eye Res, 2002,25(3) :189-196.
3Brunner M, Kletter K, Assandri A, et al.Pharmacokinetic and mass balance study of unlabelled and (14) C-labelled emedastine difumarate in healthy volunteers [J] . Xenobiotica, 2002,32 (9) :761-770.
4Verin P, Easty DL, Secchi A, et al. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis [J] . Am J Ophthalmol,2001,131 (6) :691-698.
5Orfeo V, Vardaro A, Lena P, et al. Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis [J] . Eur J Ophthalmol, 2002,12(4) :262-266.
6Endre L. Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children [J] . Orv Hetil, 2003,144 (14) :665-667.
7Vermeeren A, Ramaekers JG, O'Hanlon JF.Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females [J] . J Psychopharmacol. 2002,16(1) :57-64.
8Sharif NA, Su SX, Yanni JM . Emedastine:a potent, high affinity histamine H 1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies [J] .J Ocul Pharmacol, 1994,10 (4) :653-664.
9Sharif NA, Su SX, Yanni JM . Emedastine:a potent, high affinity histamine H 1-receptorselective antagonist for ocular use: receptor binding and second messenger studies [J] .J Ocul Pharmacol, 1994,10 (4) :653-664.
10Leonardi A, DeFranchis G, De Paoli M, et al. Histamine-induced cytokine productionand ICAM-1 expression in human conjunctival fibroblasts [J] . Curr Eye Res, 2002,25(3) :189-196.
